Self-administered Questionnaire to Evaluate Salt and Potassium Diet of Patients Followed in Nephrology (UniverSEL)

Self-administered Questionnaire to Evaluate Salt and Potassium Diet of Patients Followed in Nephrology - UniverSEL Study

The aim of the study is to create a self-questionnaire to evaluate sodium and potassium diet in chronic kidney disease patients.

Questionnaires will be compared to 24h sodium and potassium urinary excretion (reference) A Bayesian network and a multiple regression will be used to select the most relevant items

Study Overview

• Status: Completed
• Conditions: Nephropathy, Chronic Tubulointerstitial
• Intervention / Treatment: Other: Salt and potassium Diet

• Study Type: Observational
• Enrollment (Actual): 542

Contacts and Locations

Study Locations

• France
  • Lyon, France, 69003
    • Hôpital Edouard Herriot - Service de néphrologie - HTA - Dialyse

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Adult consulting in nephrology and having a 24h sodium urinary excretion routinely determined

Description

Inclusion Criteria:

• Adult consulting in nephrology and having a 24h sodium urinary excretion routinely determined
• Consent informed agreement

Exclusion Criteria:

• Do not want to participate

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The aim of the study is to create a self-administered questionnaire to evaluate sodium and potassium consumption in chronic kidney disease patients.	comparison of answers to the self-questionnaire about salt and potassium diet with natriuresis and kaliuresis urinary excretion during 24 hours	at inclusion

Collaborators and Investigators

• Sponsor: Hospices Civils de Lyon
• Investigators: Principal Investigator: Jean Pierre FAUVEL, MD, Service de néphrologie - HTA - Dialyse

Study record dates

Study Major Dates

• Study Start (ACTUAL): October 11, 2019
• Primary Completion (ACTUAL): July 15, 2020
• Study Completion (ACTUAL): July 15, 2020

Study Registration Dates

• First Submitted: December 10, 2019
• First Submitted That Met QC Criteria: December 10, 2019
• First Posted (ACTUAL): December 12, 2019

Study Record Updates

• Last Update Posted (ACTUAL): September 17, 2020
• Last Update Submitted That Met QC Criteria: September 16, 2020
• Last Verified: September 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Urologic Diseases; Nephritis; Kidney Diseases; Nephritis, Interstitial
• Other Study ID Numbers: 69HCL69_0458

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No